Fresenius Medical Care AG
FMS· NYSE
Source filing unavailable
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | €4.88B | €4.72B | €4.70B | €4.55B |
| Net Income | €151.22M | €70.96M | €86.36M | €157.36M |
| EPS Diluted | €0.52 | €0.24 | €0.29 | €0.54 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Fresenius Medical Care AG · CIK 1333141 · Engraved from SEC EDGAR